Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...

Cytokines drive immunological and therapeutic innovation, offering growth via targeted, precise treatments, strategic partnerships, and supply chain resilience, crucial for future market success.

French researchers have used a protein called receptor activator of NF-κB ligand (RANKL) to revive the structure and function of the thymus in old mice. The thymus sits in front of the heart and is ...

Researchers have developed a new method of locally delivering cytokines alongside T cells that could lead to improved CAR-T cell therapies. CAR-T cell therapies utilize engineered T cells that have a ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced study results that further demonstrate the potential for use of ...

T cells, together with B cells, are the workhorses of the adaptive immune response. And although some cells that are associated with the innate immune response can take on adaptive properties, it has ...

Stem cells are a class of multipotential cells that can self-replicate, self-renew, and differentiate into multiple cell lines. Stem cells provide a more realistic method of identifying and confirming ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...